by Colfar | agosto 23, 2017 11:18 am
Farmacovigilancia. PenbrolizumabSource URL: https://colfarsfe.org.ar/2017/08/23/pembrolizumab-keytruda-riesgo-de-reacciones-cutaneas-severas-hc-anmat/
Copyright ©2024 Colegio de Farmacéuticos de Santa Fe 1 Circ. unless otherwise noted.